Analysts Have Made A Financial Statement On Medi Assist Healthcare Services Limited's (NSE:MEDIASSIST) Second-Quarter Report

There's been a notable change in appetite for Medi Assist Healthcare Services Limited (NSE:MEDIASSIST) shares in the week since its second-quarter report, with the stock down 13% to ₹494. It was a credible result overall, with revenues of ₹2.3b and statutory earnings per share of ₹12.85 both in line with analyst estimates, showing that Medi Assist Healthcare Services is executing in line with expectations. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Following the latest results, Medi Assist Healthcare Services' three analysts are now forecasting revenues of ₹9.21b in 2026. This would be a decent 16% improvement in revenue compared to the last 12 months. Statutory earnings per share are forecast to shrink 3.6% to ₹10.55 in the same period. Before this earnings report, the analysts had been forecasting revenues of ₹9.43b and earnings per share (EPS) of ₹13.67 in 2026. The analysts seem less optimistic after the recent results, reducing their revenue forecasts and making a pretty serious reduction to earnings per share numbers.

Check out our latest analysis for Medi Assist Healthcare Services

The analysts made no major changes to their price target of ₹637, suggesting the downgrades are not expected to have a long-term impact on Medi Assist Healthcare Services' valuation. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. The most optimistic Medi Assist Healthcare Services analyst has a price target of ₹650 per share, while the most pessimistic values it at ₹630. Even so, with a relatively close grouping of estimates, it looks like the analysts are quite confident in their valuations, suggesting Medi Assist Healthcare Services is an easy business to forecast or the the analysts are all using similar assumptions.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Medi Assist Healthcare Services' past performance and to peers in the same industry. The analysts are definitely expecting Medi Assist Healthcare Services' growth to accelerate, with the forecast 34% annualised growth to the end of 2026 ranking favourably alongside historical growth of 17% per annum over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 19% annually. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Medi Assist Healthcare Services to grow faster than the wider industry.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. Regrettably, they also downgraded their revenue estimates, but the latest forecasts still imply the business will grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for Medi Assist Healthcare Services going out to 2028, and you can see them free on our platform here..

Don't forget that there may still be risks. For instance, we've identified 2 warning signs for Medi Assist Healthcare Services (1 is potentially serious) you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.